Increased plasma malondialdehyde and fructosamine in anemic H pylori infected patients: Effect of treatment

Table 1 Comparison of biochemical and hematological parameters in H pylori infected anemic patients and controls

Parameters	Control group(n = 16)	Test group(n = 22)
Hemoglobin (g/dL)	12.66 ± 0.74	6.9 ± 2.6a
Iron (μg/dL)	110.25 ± 26.58	32.72 ± 14.93a
Ferritin (ng/mL)	140.43 ± 30.72	28.82 ± 16.27a
Fructosamine (nmol/L)	1.60 ± 0.35	2.64 ± 0.93a
MDA (mmol/L)	2.26 ± 0.50	5.41 ± 2.16a
Glucose (mg/dL)	81.19 ± 9.74	83.50 ± 8.27

^aP < 0.05 vs control group.

Table 2 Changes in hematological and biochemical parameters of groups after treatment

Parameters	Group I(H pylori treatment+ oral iron therapy)(n = 11)	Group II(Oral iron therapy)(n = 11)
Hemoglobin (g/dL)
Baseline	7.42 ± 1.90	6.38 ± 2.37
1 mo after therapy	10.40 ± 1.11a	7.45 ± 1.94
Iron (μg/dL)
Baseline	36.09 ± 18.97	29.36 ± 9.10
1 mo after therapy	84.09 ± 29.51a	45.27 ± 21.36a
Ferritin (ng/mL)
Baseline	30.46 ± 17.81	27.18 ± 15.26
1 mo after therapy	116.91 ± 63.34a	52.46 ± 39.21
Fructosamine (nmol/L)
Baseline	2.28 ± 0.62	2.99 ± 1.06
1 mo after therapy	2.13 ± 0.63	2.27 ± 0.97
MDA (mmol/L)
Baseline	5.50 ± 2.46	5.32 ± 1.94
1 mo after therapy	3.11 ± 1.73a	3.81 ± 1.61

^aP < 0.05 vs the baseline value before treatment.